TY - JOUR
T1 - Metabolic profiles of Maori, Pacific, and European New Zealanders with type 2 diabetes over 25 years
AU - Yu, Dahai
AU - Cai, Yamei
AU - Osuagwu, Uchechukwu Levi
AU - Pickering, Karen
AU - Baker, John
AU - Cutfield, Richard
AU - Jansen, Rawiri McKree
AU - Orr-Walker, Brandon J.
AU - Sundborn, Gerhard
AU - Zhao, Zhanzheng
AU - Simmons, David
PY - 2021
Y1 - 2021
N2 - The population of New Zealand includes a high proportion of Maori (Indigenous Polynesian) and Pacific (Pasifika) people, who have been shown to experience worse type 2 diabetes mellitus (T2DM) outcomes than New Zealand Europeans (NZE), a phenomenon persisting for >20 years (1). It remains unclear which metabolic targets are not being achieved concurrent with these long-standing disparities in diabetes complications. In this study we compared five key clinical measurements routinely assessed in primary care (systolic blood pressure [SBP], BMI, HbA1c, total cholesterol [TC], and triglyceride [TG]) over time among patients with T2DM from these three main ethnic groups (Maori, NZE, and Pasifika).
AB - The population of New Zealand includes a high proportion of Maori (Indigenous Polynesian) and Pacific (Pasifika) people, who have been shown to experience worse type 2 diabetes mellitus (T2DM) outcomes than New Zealand Europeans (NZE), a phenomenon persisting for >20 years (1). It remains unclear which metabolic targets are not being achieved concurrent with these long-standing disparities in diabetes complications. In this study we compared five key clinical measurements routinely assessed in primary care (systolic blood pressure [SBP], BMI, HbA1c, total cholesterol [TC], and triglyceride [TG]) over time among patients with T2DM from these three main ethnic groups (Maori, NZE, and Pasifika).
UR - https://hdl.handle.net/1959.7/uws:63042
U2 - 10.2337/dc21-1255
DO - 10.2337/dc21-1255
M3 - Article
SN - 0149-5992
VL - 44
SP - e183-e185
JO - Diabetes Care
JF - Diabetes Care
IS - 10
ER -
